gemcitabine and carboplatin

DRUG4 trials

Sponsors

National University Hospital, Singapore, Hamamatsu University, Kyowa Kirin Co., Ltd., Piramal Enterprises Limited

Conditions

Breast CancerFallopian Tube NeoplasmsNeoplasmsNon Small Cell Lung CancerNon-Small Cell Lung CancerOvarian NeoplasmsPrimary Peritoneal Neoplasm

Phase 1

Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

TerminatedNCT01279291

Kyowa Kirin Co., Ltd.Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms +1

Start: 2011-01-31End: 2012-11-30Updated: 2024-04-26

A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin

TerminatedNCT01333137

Piramal Enterprises LimitedBreast Cancer

Start: 2011-08-31End: 2014-03-31Updated: 2014-09-04

Phase 2

The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients

CompletedNCT00695994

National University Hospital, SingaporeBreast Cancer, Non Small Cell Lung Cancer

Start: 2006-10-31End: 2012-09-30Updated: 2012-11-01

Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer

CompletedNCT00881296

Hamamatsu UniversityNon-Small Cell Lung Cancer

Start: 2008-03-31End: 2011-06-30Updated: 2011-09-07

Related Papers

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy

BMC Cancer2018-05-1121 citations